Schedule 13G ownership disclosure

ONCOMED PHARMACEUTICALS INC

Security class unavailable · CUSIP: 68234X102

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,839,730
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000914760-17-000027
Form type
SC 13G/A
Filer
ADAMS STREET PARTNERS LLC
CIK
CIK 1193586
Filed
Feb 13, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub